Optimizing the strain engineering process for industrial-scale production of bio-based molecules
Journal of Industrial Microbiology and Biotechnology · 17.02.2023 · 50 (1)
DOI: 10.1093/jimb/kuad025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, online erschienen am 01.09.2023. Verfasst von Eric Abbate und 25 weiteren Autor:innen. Beteiligte Einrichtung: Inscripta, Inc., 5720 Stoneridge Dr, Suite 300, Pleasanton, CA 94588, USA. Hauptthemen laut MEDLINE: Metabolic Engineering, Industrial Microbiology. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inscripta, Inc.
Abstract (Originalsprache)
Biomanufacturing could contribute as much as ${\$}$30 trillion to the global economy by 2030. However, the success of the growing bioeconomy depends on our ability to manufacture high-performing strains in a time- and cost-effective manner. The Design–Build–Test–Learn (DBTL) framework has proven to be an effective strain engineering approach. Significant improvements have been made in genome engineering, genotyping, and phenotyping throughput over the last couple of decades that have greatly accelerated the DBTL cycles. However, to achieve a radical reduction in strain development time and cost, we need to look at the strain engineering process through a lens of optimizing the whole cycle, as opposed to simply increasing throughput at each stage. We propose an approach that integrates all 4 stages of the DBTL cycle and takes advantage of the advances in computational design, high-throughput genome engineering, and phenotyping methods, as well as machine learning tools for making predictions about strain scale-up performance. In this perspective, we discuss the challenges of industrial strain engineering, outline the best approaches to overcoming these challenges, and showcase examples of successful strain engineering projects for production of heterologous proteins, amino acids, and small molecules, as well as improving tolerance, fitness, and de-risking the scale-up of industrial strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inscripta, Inc., 5720 Stoneridge Dr, Suite 300, Pleasanton, CA 94588, USA.
ORCID-Profile: Eric Abbate
Förderung
- Inscripta, Inc
Zitieren
APA
Abbate, E., Andrion, J., Apel, A., Biggs, M., Chaves, J., Cheung, K., Ciesla, A., Clark-ElSayed, A., Clay, M., Contridas, R., Fox, R., Hein, G., Held, D., Horwitz, A., Jenkins, S., Kalbarczyk, K., Krishnamurthy, N., Mirsiaghi, M., Noon, K., …, & Yerramsetty, K. (2023). Optimizing the strain engineering process for industrial-scale production of bio-based molecules. Journal of Industrial Microbiology and Biotechnology, 50(1). https://doi.org/10.1093/jimb/kuad025
Vancouver
Abbate E, Andrion J, Apel A, Biggs M, Chaves J, Cheung K, et al. Optimizing the strain engineering process for industrial-scale production of bio-based molecules. Journal of Industrial Microbiology and Biotechnology. 2023;50(1). doi:10.1093/jimb/kuad025
BibTeX
@article{Abbate2023,
author = {Abbate, Eric and Andrion, Jennifer and Apel, Amanda and Biggs, Matthew and Chaves, Julie and Cheung, Kristi and Ciesla, Anthony and Clark-ElSayed, Alia and Clay, Michael and Contridas, Riarose and Fox, Richard and Hein, Glenn and Held, Dan and Horwitz, Andrew and Jenkins, Stefan and Kalbarczyk, Karolina and Krishnamurthy, Nandini and Mirsiaghi, Mona and Noon, Katherine and Rowe, Mike and Shepherd, Tyson and Tarasava, Katia and Tarasow, Theodore M and Thacker, Drew and Villa, Gladys and Yerramsetty, Krishna},
title = {Optimizing the strain engineering process for industrial-scale production of bio-based molecules},
journal = {Journal of Industrial Microbiology and Biotechnology},
year = {2023},
volume = {50},
number = {1},
doi = {10.1093/jimb/kuad025}
}
EUVIMED